Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIAID

CELLS EXPRESSING BOTH HUMAN CD4 AND A HUMAN FUSION ACCESSORY FACTOR ASSOCIATED WITH HIV INFECTION

  • Read more about CELLS EXPRESSING BOTH HUMAN CD4 AND A HUMAN FUSION ACCESSORY FACTOR ASSOCIATED WITH HIV INFECTION
Patent Cooperation Treaty
PCT/US1997/000956
Filed on 1997-01-30

Inhibitors of Formation of Protease Resistant Prion Protein

  • Read more about Inhibitors of Formation of Protease Resistant Prion Protein
US Patent 6,211,149
Filed on 1998-08-03

CC CHEMOKINE RECEPTOR 8 DNA, NEW ANIMAL MODELS AND THERAPEUTIC AGENTS FOR HIV INFECTION

  • Read more about CC CHEMOKINE RECEPTOR 8 DNA, NEW ANIMAL MODELS AND THERAPEUTIC AGENTS FOR HIV INFECTION
US Application 09/124,955
Filed on 1998-07-29

NEUTRALIZING MONOCLONAL ANTIBODIES TO RESPIRATORY SYNCYTIAL VIRUS

  • Read more about NEUTRALIZING MONOCLONAL ANTIBODIES TO RESPIRATORY SYNCYTIAL VIRUS
US Application 09/043,530
Filed on 1998-03-18

PERTUSSIS TOXIN GENE: CLONING AND EXPRESSION OF PROTECTIVE ANTIGEN

  • Read more about PERTUSSIS TOXIN GENE: CLONING AND EXPRESSION OF PROTECTIVE ANTIGEN
US Application 09/128,911
Filed on 1998-08-04

Methods of Inactivating Enveloped RNA Virus Particles and Compositions for Use Therein

  • Read more about Methods of Inactivating Enveloped RNA Virus Particles and Compositions for Use Therein
Patent Cooperation Treaty
PCT/US1998/013852
Filed on 1998-07-02

OLIGOMERIC HIV-1 ENVELOPE GLYCOPROTEINS

  • Read more about OLIGOMERIC HIV-1 ENVELOPE GLYCOPROTEINS
US Patent 6,171,596
Filed on 1998-04-30

ISOLATION, CHARACTERIZATION, AND USE OF THE HUMAN BETA SUBUNIT OF THE HIGH AFFINITY RECEPTOR FOR IMMUNOGLOBULIN E

  • Read more about ISOLATION, CHARACTERIZATION, AND USE OF THE HUMAN BETA SUBUNIT OF THE HIGH AFFINITY RECEPTOR FOR IMMUNOGLOBULIN E
US Patent 6,171,803
Filed on 1998-06-23

Method of Decreasing Radiation or Radio-Mimetic Chemotherapy for Hematopoietic Pluripotent Cell Engraftment

  • Read more about Method of Decreasing Radiation or Radio-Mimetic Chemotherapy for Hematopoietic Pluripotent Cell Engraftment
Patent Cooperation Treaty
PCT/US1996/012368
Filed on 1996-07-22

Method Of Sampling, Amplifying And Quantifying Segment Of Nucleic Acid ...

  • Read more about Method Of Sampling, Amplifying And Quantifying Segment Of Nucleic Acid ...
Patent Cooperation Treaty
PCT/US1998/007746
Filed on 1998-04-17

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 554
  • Page 555
  • Page 556
  • Page 557
  • Page 558
  • Page 559
  • Page 560
  • Page 561
  • Page 562
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIAID
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health